Results 251 to 260 of about 435,610 (360)
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li+9 more
wiley +1 more source
<i>Pediococcus pentosaceus</i> MZF16 Probiotic Strain Prevents In Vitro Cytotoxic Effects of <i>Pseudomonas aeruginosa</i> H103 and Prolongs the Lifespan of <i>Caenorhabditis elegans</i>. [PDF]
Boujnane M+6 more
europepmc +1 more source
Liver Function Tests Profile in Cancer Patients on Cytotoxic Chemotherapy: A preliminary report
SA Akuyam+6 more
openalex +1 more source
A magnetic microrobot fabricated by Spirulina platensis is proposed to accumulate in tumor regions and generate in situ high calcium concentration and sufficient oxygen. These characteristics of the microrobot present a strategy for triggering calcium overload therapy and chlorophyll‐mediated photodynamic therapy, and such combination resulted in a ...
Shuai Jiang+12 more
wiley +1 more source
Fabrication and Evaluation of Polyhydroxyalkanoate-Based Nanoparticles for Curcumin Delivery in Biomedical Applications. [PDF]
Sha'at F+8 more
europepmc +1 more source
Isolation and Cytotoxicity Test of Dichloromethane Extract of Syzygium malaccense [PDF]
Novirlin Daely, Tukiran Tukiran
openalex +1 more source
NeoCast is a next‐generation, solvent‐free, non‐adhesive liquid embolic designed for indications where deep occlusion is desired (e.g., tumors and chronic subdural hematoma). This novel agent offers ideal embolic properties: injectability, controllability, excellent visibility, and biocompatibility.
Quynh P. Pham+16 more
wiley +1 more source
Polymeric Materials Used in 3DP in Dentistry-Biocompatibility Testing Challenges. [PDF]
Rus F+10 more
europepmc +1 more source
Minimal residual disease (MRD) leads to cancer relapse and poor survival in ovarian cancer. The lack of representative 3D models limits therapy development. The microfluidics‐based high throughput 3D microtumor platform described here generates clinically‐relevant MRD models. The 3D microtumors recapitulate the molecular signatures of MRD from patients.
Xingyun Yang+14 more
wiley +1 more source